Paper · 32674458
Peroxisome Metabolism in Cancer.
Kim JA. Cells, 2020. Cited by 97 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Peroxisome Metabolism in Cancer. Papers, record 32674458. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32674458
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Neoplasms | Major topic |
| Peroxisomes | Major topic |
| Animals | |
| Biosynthetic Pathways | |
| Homeostasis | |
| Humans | |
| Models, Biological | |
| Reactive Oxygen Species |
Source PubMed
Grants0
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
None in this release.
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References122
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 24,841,318 | Role and mechanism of the alkylglycerone phosphate synthase in suppressing the invasion potential of human glioma and hepatic carcinoma cells in vitro. | Oncol Rep | 2014 | https://conductscience.org/library/papers/24841318 | PubMed |
| 2 | 25,639,644 | Localization of MCT2 at peroxisomes is associated with malignant transformation in prostate cancer. | J Cell Mol Med | 2015 | https://conductscience.org/library/papers/25639644 | PubMed |
| 3 | 24,712,326 | Trifluoroibuprofen inhibits α-methylacyl coenzyme A racemase (AMACR/P504S), reduces cancer cell proliferation and inhibits in vivo tumor growth in aggressive prostate cancer models. | Anticancer Agents Med Chem | 2014 | https://conductscience.org/library/papers/24712326 | PubMed |
| 4 | 17,008,281 | Abundant expression of AMACR in many distinct tumour types. | Pathology | 2006 | https://conductscience.org/library/papers/17008281 | PubMed |
| 5 | 28,527,945 | Targeting lipid metabolism of cancer cells: A promising therapeutic strategy for cancer. | Cancer Lett | 2017 | https://conductscience.org/library/papers/28527945 | PubMed |
| 6 | 23,980,144 | Ether lipid generating enzyme AGPS alters the balance of structural and signaling lipids to fuel cancer pathogenicity. | Proc Natl Acad Sci U S A | 2013 | https://conductscience.org/library/papers/23980144 | PubMed |
| 7 | 18,279,392 | Alpha-methylacyl-CoA racemase--an 'obscure' metabolic enzyme takes centre stage. | FEBS J | 2008 | https://conductscience.org/library/papers/18279392 | PubMed |
| 8 | 12,705,896 | Peroxisomal membrane monocarboxylate transporters: evidence for a redox shuttle system? | Biochem Biophys Res Commun | 2003 | https://conductscience.org/library/papers/12705896 | PubMed |
| 9 | 26,344,566 | ATM functions at the peroxisome to induce pexophagy in response to ROS. | Nat Cell Biol | 2015 | https://conductscience.org/library/papers/26344566 | PubMed |
| 10 | 10,725,470 | Hydrogen peroxide generation in peroxisome proliferator-induced oncogenesis. | Mutat Res | 2000 | https://conductscience.org/library/papers/10725470 | PubMed |
1 to 10 of 122
See all 122 referencesCited by64
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 97 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,964,345 | Cinobufagin induces peroxisome dysfunction through suppression of the peroxisomal biogenesis factor proteins and interferes with lipid metabolism to affect the growth of liver cancer cells. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/42964345 | PubMed |
| 42,792,605 | Exploratory Transcriptomic, Genomic, Pharmacogenomic, and Cellular Evaluation of FKBP4 in Lung Adenocarcinoma. | Biology (Basel) | 2026 | https://conductscience.org/library/papers/42792605 | PubMed |
| 42,769,853 | FSCN1 Modulates Fatty Acid Metabolism and the Coordinated Activation of AKT/mTOR and p38 MAPK Pathways in Colorectal Cancer Cells. | Oncol Res | 2026 | https://conductscience.org/library/papers/42769853 | PubMed |
| 42,372,295 | Continuous multi-omics pathway enrichment analysis resolves hidden functional heterogeneity. | Brief Bioinform | 2026 | https://conductscience.org/library/papers/42372295 | PubMed |
| 42,352,361 | Peroxisomes in Liver Diseases: From Metabolite Quality Control to Inter-Organelle and Inter-Organ Signaling. | Biomolecules | 2026 | https://conductscience.org/library/papers/42352361 | PubMed |
| 42,298,691 | Analysis and validation of abnormal signaling pathways and immune cell infiltration characteristics in digestive system cancers based on peroxisome-related genes. | Biol Direct | 2026 | https://conductscience.org/library/papers/42298691 | PubMed |
| 42,290,140 | Peroxisomal Lipid Metabolism as a Therapeutic Target in Leukemia. | Mol Nutr Food Res | 2026 | https://conductscience.org/library/papers/42290140 | PubMed |
| 41,977,190 | Oxidative Stress in Multiple Myeloma: Pathogenic Mechanisms, Biomarkers, and Redox-Targeted Therapeutic Strategies. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/41977190 | PubMed |
| 41,902,194 | Remodeling of Metabolic and Secretory Organelles During Oncogenic and Oncomodulatory Viral Infections. | Viruses | 2026 | https://conductscience.org/library/papers/41902194 | PubMed |
| 41,858,347 | Peroxisomal activity drives aggressive bladder cancer phenotypes and reveals erythorbic acid as a potential therapeutic modulator. | Front Oncol | 2026 | https://conductscience.org/library/papers/41858347 | PubMed |
1 to 10 of 64
See all 64 cited byGenes46
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ABCD2 | 225 | PubTator's text mining | https://conductscience.org/library/genes/225 | NCBI Gene |
| ABCD3 | 5,825 | PubTator's text mining | https://conductscience.org/library/genes/5825 | NCBI Gene |
| ACAA1 | 30 | PubTator's text mining | https://conductscience.org/library/genes/30 | NCBI Gene |
| ACOX1 | 51 | PubTator's text mining | https://conductscience.org/library/genes/51 | NCBI Gene |
| ACOX2 | 8,309 | PubTator's text mining | https://conductscience.org/library/genes/8309 | NCBI Gene |
| ACOX3 | 8,310 | PubTator's text mining | https://conductscience.org/library/genes/8310 | NCBI Gene |
| ACSL4 | 2,182 | PubTator's text mining | https://conductscience.org/library/genes/2182 | NCBI Gene |
| AGPS | 8,540 | PubTator's text mining | https://conductscience.org/library/genes/8540 | NCBI Gene |
| ALDH3A2 | 224 | PubTator's text mining | https://conductscience.org/library/genes/224 | NCBI Gene |
| AMACR | 23,600 | PubTator's text mining | https://conductscience.org/library/genes/23600 | NCBI Gene |
1 to 10 of 46
See all 46 genesDrugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/32674458
GET https://conductscience.org/api/papers/v1/32674458/references?page=2